Exploring the potential of weight loss drugs to improve workplace productivity in the UK
The British government recently unveiled a major pharmaceutical collaboration with Eli Lilly to conduct a five-year study into the effects of the weight-loss drug tirzepatide, known commercially as Mounjaro. This initiative aims to determine whether such drugs could not only help people lose weight but also improve productivity levels within the workforce. In Britain, obesity is a growing concern, with around one in four adults classed as obese. This epidemic places a heavy financial burden on the National Health Service, costing billions every year. The government's new strategy suggests that tirzepatide injections could potentially be a viable solution to this…